Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience

被引：0
|
作者：
Oscar Epis
Cinzia Casu
Laura Belloli
Emanuela Schito
Davide Filippini
Marina Muscarà
Eleonora Bruschi
机构：
[1] Niguarda Ca’ Granda Hospital,Rheumatology Unit
来源：
Rheumatology International | 2015年 / 35卷
关键词：
Rheumatoid Arthritis; Rheumatoid Arthritis Patient; Clinical Remission; Tocilizumab; Disease Remission;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1569 / 1570
页数：1
相关论文
共 50 条
  • [21] RELATIONSHIP BETWEEN CLINICAL REMISSION AND SERUM LEVELS OF TOCILIZUMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS
    Ruiz-Esquide, V.
    Zufferey, P.
    Yaguee, J.
    Berner, J.
    Inciarte-Mundo, J.
    Gonzalez-Navarro, A.
    Hernandez, V.
    Ramirez, J.
    Cuervo, A.
    Canete, J.
    Sanmarti, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 77 - 77
  • [22] EFFICACY AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL PRACTICE: TWO YEARS' EXPERIENCE
    Quesada-Masachs, Estefania
    Carolina Diaz, Ana
    Avila, Gabriela
    Acosta, Isabel
    Sans, Xavier
    Alegre, Cayetano
    Marsal, Sara
    RHEUMATOLOGY, 2012, 51 : 137 - 137
  • [23] Decrease of Tocilizumab Dose in Patients with Rheumatoid Arthritis: A Pilot Study
    Fechtenbaum, Marie
    Lasselin-Boyard, Pauline
    Salomon, Sarah
    Jelin, Germain
    Millot, Florence
    Grados, Franck
    Fardellone, Patrice
    Goeb, Vincent
    PHARMACOLOGY, 2016, 98 (1-2) : 73 - 78
  • [24] Dose Modification of Subcutaneous Tocilizumab in Patients with Rheumatoid Arthritis Response
    Punekar, Rajeshwari
    Choi, Jeannie
    Boklage, Susan H.
    Iglesias-Rodriguez, Melitza
    Nola, Kamala
    AMERICAN HEALTH AND DRUG BENEFITS, 2020, 13 (02): : 73 - 73
  • [25] CLINICAL AND SEROLOGICAL RESPONSE TO TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Casu, C.
    Bruschi, E.
    Alpini, C.
    Marceglia, S.
    Giacomelli, L.
    Epis, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 880 - 880
  • [26] Achieving Clinical Remission for Patients With Rheumatoid Arthritis
    Aletaha, Daniel
    Smolen, Josef S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (05): : 457 - 458
  • [27] Decrease of Tocilizumab in Rheumatoid Arthritis in Remission : A Multicenter Study
    Desbarbieux, Renaud
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [28] THE LENGHT OF REMISSION AND RATE OF RELAPSE AFTER TOCILIZUMAB WITHDRAWAL IN RHEUMATOID ARTHRITIS PATIENTS
    Aguilar-Lozano, L.
    Padilla-Ibarra, J.
    Sandoval-Castro, C.
    Castillo-Ortiz, J. D.
    Morales-Torres, J.
    Hernandez, C.
    Burgos-Vargas, R.
    Pacheco-Tena, C.
    Ramos-Remus, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 69 - 70
  • [29] Remission in rheumatoid arthritis patients treated with etanercept monotherapy: clinical practice and clinical trial experience
    Cannon, G. W.
    Wang, B. C.
    Park, G. S.
    Koenig, A.
    Collier, D. H.
    Keystone, E. C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (06) : 919 - 925
  • [30] Clinical safety of tocilizumab in rheumatoid arthritis
    Bannwarth, Bernard
    Richez, Christophe
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (01) : 123 - 131
12345